Christopher W. Fulton

Array ( [id] => 7688943 [patent_doc_number] => 20070105755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'One pot desialylation and glycopegylation of therapeutic peptides' [patent_app_type] => utility [patent_app_number] => 11/580669 [patent_app_country] => US [patent_app_date] => 2006-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 65 [patent_figures_cnt] => 65 [patent_no_of_words] => 42999 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20070105755.pdf [firstpage_image] =>[orig_patent_app_number] => 11580669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5051891 [patent_doc_number] => 20070032436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Pharmaceutical formulations' [patent_app_type] => utility [patent_app_number] => 11/546713 [patent_app_country] => US [patent_app_date] => 2006-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9417 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20070032436.pdf [firstpage_image] =>[orig_patent_app_number] => 11546713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 602531 [patent_doc_number] => 07432294 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-07 [patent_title] => 'Pharmaceutical formulations' [patent_app_type] => utility [patent_app_number] => 11/546673 [patent_app_country] => US [patent_app_date] => 2006-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8916 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/432/07432294.pdf [firstpage_image] =>[orig_patent_app_number] => 11546673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7688916 [patent_doc_number] => 20070105782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Protectant Combinations for Reducing Toxicities' [patent_app_type] => utility [patent_app_number] => 11/539975 [patent_app_country] => US [patent_app_date] => 2006-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13452 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20070105782.pdf [firstpage_image] =>[orig_patent_app_number] => 11539975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6636404 [patent_doc_number] => 20100035824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-11 [patent_title] => 'Synergistic Pharmaceutical Composition' [patent_app_type] => utility [patent_app_number] => 12/089933 [patent_app_country] => US [patent_app_date] => 2006-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5022 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20100035824.pdf [firstpage_image] =>[orig_patent_app_number] => 12089933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5086074 [patent_doc_number] => 20070276125 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'Methods for inhibiting immune complex formation in a subject' [patent_app_type] => utility [patent_app_number] => 11/537710 [patent_app_country] => US [patent_app_date] => 2006-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 21110 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0276/20070276125.pdf [firstpage_image] =>[orig_patent_app_number] => 11537710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5205690 [patent_doc_number] => 20070027172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Crystalline pharmaceutical' [patent_app_type] => utility [patent_app_number] => 11/542075 [patent_app_country] => US [patent_app_date] => 2006-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 12136 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20070027172.pdf [firstpage_image] =>[orig_patent_app_number] => 11542075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5225584 [patent_doc_number] => 20070254851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'Chemically-defined non-polymeric valency platform molecules and conjugates thereof' [patent_app_type] => utility [patent_app_number] => 11/542313 [patent_app_country] => US [patent_app_date] => 2006-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 31201 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20070254851.pdf [firstpage_image] =>[orig_patent_app_number] => 11542313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5106634 [patent_doc_number] => 20070065511 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'Controlled delivery creatine formulations and method of using the same' [patent_app_type] => utility [patent_app_number] => 11/519297 [patent_app_country] => US [patent_app_date] => 2006-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6615 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20070065511.pdf [firstpage_image] =>[orig_patent_app_number] => 11519297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6477719 [patent_doc_number] => 20100041612 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'Fragments of the Glucagon-Like Peptide-1 and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 11/991661 [patent_app_country] => US [patent_app_date] => 2006-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15408 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20100041612.pdf [firstpage_image] =>[orig_patent_app_number] => 11991661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5063591 [patent_doc_number] => 20070225231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => 'Methods for inhibiting immune complex formation in a subject' [patent_app_type] => utility [patent_app_number] => 11/530273 [patent_app_country] => US [patent_app_date] => 2006-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 21093 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20070225231.pdf [firstpage_image] =>[orig_patent_app_number] => 11530273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4983413 [patent_doc_number] => 20070087972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-19 [patent_title] => 'Prion-specific peptoid reagents' [patent_app_type] => utility [patent_app_number] => 11/518091 [patent_app_country] => US [patent_app_date] => 2006-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 36058 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20070087972.pdf [firstpage_image] =>[orig_patent_app_number] => 11518091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5219257 [patent_doc_number] => 20070160568 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'Polyamino acids functionalized by at least one hydrophobic group and the therapeutic application thereof' [patent_app_type] => utility [patent_app_number] => 11/509783 [patent_app_country] => US [patent_app_date] => 2006-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4852 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20070160568.pdf [firstpage_image] =>[orig_patent_app_number] => 11509783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5142483 [patent_doc_number] => 20070004699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING ATHEROMA, TUMORS AND OTHER NEOPLASTIC TISSUES' [patent_app_type] => utility [patent_app_number] => 11/465054 [patent_app_country] => US [patent_app_date] => 2006-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 15972 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20070004699.pdf [firstpage_image] =>[orig_patent_app_number] => 11465054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5570516 [patent_doc_number] => 20090253895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'Printable Materials' [patent_app_type] => utility [patent_app_number] => 11/990437 [patent_app_country] => US [patent_app_date] => 2006-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8806 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20090253895.pdf [firstpage_image] =>[orig_patent_app_number] => 11990437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5416348 [patent_doc_number] => 20090042235 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'PHOTOREGULATED PEPTIDE, AND METHOD FOR REGULATION OF PEPTIDE-PROTEIN COMPLEX FORMATION USING THE PHOTOREGULATED PEPTIDE' [patent_app_type] => utility [patent_app_number] => 12/063569 [patent_app_country] => US [patent_app_date] => 2006-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6213 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20090042235.pdf [firstpage_image] =>[orig_patent_app_number] => 12063569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4652106 [patent_doc_number] => 20080039362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'Combination drug therapy for reducing scar tissue formation' [patent_app_type] => utility [patent_app_number] => 11/501371 [patent_app_country] => US [patent_app_date] => 2006-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 29916 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20080039362.pdf [firstpage_image] =>[orig_patent_app_number] => 11501371 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 820712 [patent_doc_number] => 07408045 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-05 [patent_title] => 'Adsorbent of high-mobility-group protein and body fluid-purification column' [patent_app_type] => utility [patent_app_number] => 11/490095 [patent_app_country] => US [patent_app_date] => 2006-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3829 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/408/07408045.pdf [firstpage_image] =>[orig_patent_app_number] => 11490095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4574128 [patent_doc_number] => 07829665 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-09 [patent_title] => 'Macrocyclic inhibitors of hepatitis C virus replication' [patent_app_type] => utility [patent_app_number] => 11/491126 [patent_app_country] => US [patent_app_date] => 2006-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 115808 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/829/07829665.pdf [firstpage_image] =>[orig_patent_app_number] => 11491126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5338055 [patent_doc_number] => 20090054519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'DERIVATIVES OF MONOSACCHARIDES AS 5-LIPOXYGENASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 11/996407 [patent_app_country] => US [patent_app_date] => 2006-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8201 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20090054519.pdf [firstpage_image] =>[orig_patent_app_number] => 11996407 [rel_patent_id] =>[rel_patent_doc_number] =>)